IRIS
CROTTI, LIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.399
AS - Asia 3.447
EU - Europa 3.081
SA - Sud America 369
AF - Africa 47
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 9
Totale 11.381
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.282
CN - Cina 2.040
IE - Irlanda 798
SG - Singapore 714
HK - Hong Kong 393
UA - Ucraina 386
IT - Italia 372
RU - Federazione Russa 363
FI - Finlandia 353
DE - Germania 348
BR - Brasile 291
GB - Regno Unito 150
VN - Vietnam 131
SE - Svezia 106
CA - Canada 83
FR - Francia 64
IN - India 38
AR - Argentina 34
BE - Belgio 34
BD - Bangladesh 26
JP - Giappone 26
MX - Messico 22
AT - Austria 20
PL - Polonia 20
ZA - Sudafrica 18
AU - Australia 17
EC - Ecuador 15
NL - Olanda 14
NZ - Nuova Zelanda 12
ES - Italia 10
CO - Colombia 9
KE - Kenya 9
MA - Marocco 9
IQ - Iraq 8
TR - Turchia 7
CH - Svizzera 6
CL - Cile 6
EU - Europa 6
IR - Iran 6
PK - Pakistan 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
ID - Indonesia 5
UZ - Uzbekistan 5
VE - Venezuela 5
BG - Bulgaria 4
JO - Giordania 4
KR - Corea 4
LT - Lituania 4
LU - Lussemburgo 4
PE - Perù 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
GR - Grecia 3
IL - Israele 3
KG - Kirghizistan 3
KZ - Kazakistan 3
PA - Panama 3
RO - Romania 3
AL - Albania 2
EG - Egitto 2
ET - Etiopia 2
LV - Lettonia 2
NO - Norvegia 2
OM - Oman 2
PY - Paraguay 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BB - Barbados 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CM - Camerun 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DZ - Algeria 1
GA - Gabon 1
GE - Georgia 1
GI - Gibilterra 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
MU - Mauritius 1
MY - Malesia 1
NI - Nicaragua 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
TH - Thailandia 1
TJ - Tagikistan 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 11.381
Salva come PNG Salva come JPEG
Città #
Dublin 795
Chandler 708
Jacksonville 493
Nanjing 436
Hong Kong 389
Beijing 381
Dallas 368
Ashburn 354
Singapore 320
Boardman 199
Nanchang 171
Wilmington 145
Princeton 140
Lawrence 138
Shenyang 135
Changsha 121
Helsinki 120
Hebei 119
Ann Arbor 118
Jiaxing 108
Los Angeles 104
Medford 97
Milan 94
New York 76
Hangzhou 71
Pavia 66
Shanghai 66
Tianjin 63
Redondo Beach 61
Moscow 59
Buffalo 53
Ho Chi Minh City 50
Munich 49
Toronto 42
Woodbridge 36
Brussels 29
São Paulo 29
Norwalk 27
Seattle 27
Tokyo 26
Houston 24
Falkenstein 23
Verona 23
Fairfield 21
Hanoi 21
Turku 21
Nuremberg 20
Ottawa 19
Brooklyn 18
Zhengzhou 18
Warsaw 17
Frankfurt am Main 16
Kunming 16
Johannesburg 15
San Francisco 15
Chicago 14
Denver 14
Falls Church 14
The Dalles 14
Guangzhou 13
Trieste 13
Bergamo 12
Boston 12
Des Moines 12
Florence 11
Jinan 11
London 11
Pune 11
Stockholm 11
Columbus 10
Montreal 10
Santa Clara 10
Chennai 9
Phoenix 9
Atlanta 8
Belo Horizonte 8
Berlin 8
Manchester 8
Nairobi 8
Piscataway 8
Rochester 8
Secaucus 8
Orange 7
Poplar 7
Vienna 7
Amsterdam 6
Auburn Hills 6
Brasília 6
Brisbane 6
Liverpool 6
Lodi 6
Mexico City 6
Modena 6
Quito 6
Sydney 6
Travaco Siccomario 6
Washington 6
Antwerp 5
Auckland 5
Bexley 5
Totale 7.563
Salva come PNG Salva come JPEG
Nome #
Mapping the human genetic architecture of COVID-19 273
A first update on mapping the human genetic architecture of COVID-19 161
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. 137
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis. 125
Long QT and short QT syndromes. 125
Gene symbol: KCNH2 124
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome. 120
Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome. 119
Spectrum and prevalence of mutations involving BrS1-12 susceptibility genes in a cohort of unrelated patients referred for Brugada Syndrome genetic testing: implications for genetic testing. 117
FGF12 is a candidate Brugada syndrome locus. 114
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 113
AKAP9 is a genetic modifier of congenuital Long-QT Syndrome type 1 109
Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1. 104
Novel human pathological mutations. Gene symbol: SCN5A. Disease: Brugada Syndrome. 103
The LQT2 KCNH2-Q376Q splicing muation: functional characterization, molecular correction and therapeutic implication. 101
Long QT syndrome-associated mutations in intrauterine fetal death. 101
Electrocardiographic and genetic screening for long QT syndrome: results from a prospective study on 44,596 neonates. 100
Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study 100
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 100
Inherited cardiac arrhythmia syndrome. Role of potassium channels 98
QT lungo, sindrome del 98
Cardiac potassium channel dysfunction in sudden infant death syndrome. 98
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents. 98
Cardiac arrhythmias of genetic origin are important contributors to Sudden Infant Death Syndrome. 96
All LQT3 patients need an ICD. True or false? 96
Cardiac sodium channel dysfunction in sudden infant death syndrome. 94
Arrhythmogenic disorders of genetic origin. Long QT Syndrome: from genetics to management. 94
A comprehensive electrocardiographic, molecular, and echocardiographic study of Brugada syndrome: validation of the 2013 diagnostic criteria. 93
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 93
A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5. 92
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 92
Can a message from the dead save lives? 91
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene 91
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 91
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. 90
Individual autonomic profile contributes to the risk for life-threatening arrhythmias among KCNQ1-A341V mutation carriers 89
The ICD for the long QT syndrome: which indications, complications, and results? 89
Prevalence of the congenital long-QT syndrome. 89
The genetics underlying acquired long QT syndrome: impact for genetic screening. 89
Brugada and Long QT Syndrome are two different diseases: True or False? 88
Congenital long QT and short QT syndromes 88
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 88
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome. 87
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation 87
Arrhythmogenic calmodulin mutations disrupt intracellular cardiomyocyte Ca2+ regulation by distinct mechanisms. 85
Response to Letters Regarding Article, "Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation" 85
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 85
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2 84
Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. 83
Idiopathic Ventricular Fibrillation. 83
Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients. 82
Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1? 82
A Refined Multiscale Self-Entropy Approach for the Assessment of Cardiac Control Complexity: Application to Long QT Syndrome Type 1 Patients 81
Genotype-Phenotype Correlation in Induced Pluripotent Stem Cell (iPSC) Derived Cardiomyocytes Carrying Calmodulin Mutations 81
KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome. 81
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 80
Condizioni cliniche associate ad anomalie dell'intervallo QT: Implicazioni cliniche [Clinical conditions associated with abnormal QT interval: clinical implications]. 80
Autonomic control of heart rate and QT interval variability influences arrhythmic risk in long QT syndrome type 1 80
Impact of clinical and genetic findings on the management of young patients with Brugada syndrome. 80
An International Multi-Center Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition. 80
NOS1AP Is a Genetic Modifier of the Long-QT Syndrome 79
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation 79
Risk factors for primary ventricular fibrillation during a first myocardial infarction: Clinical findings from PREDESTINATION (PRimary vEntricular fibrillation and suDden dEath during firST myocardIal iNfArcTION) 79
QTc behavior during exercise and genetic testing for the long-QT syndrome. 78
Gene symbol: KCNH2 78
Clinical implications for patients with Long QT Syndrome who experience a cardiac event during infancy 78
Two cases of sudden unexpected death in epilepsy in a GEFS+ family with an SCN1A mutation. 77
Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population 77
Gene symbol: SCN5A 76
Torsades de Pointes following Acute Myocardial Infarction: Evidence for a Deadly Link with a Common Genetic Variant. 76
Filtering approach based on empirical mode decomposition improves the assessment of short scale complexity in long QT syndrome type 1 population 76
Clinical management of catecholaminergic polymorphic ventricular tachycardia the role of left cardiac sympathetic denervation 76
Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation. 75
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1 75
The Long QT Syndrome 73
Refined multiscale entropy analysis of heart period and QT interval variabilities in long QT syndrome type-1 patients2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) 73
Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study. 73
High efficacy of beta-blockers in Long QT Syndrome type 1: contribution of non-compliance and QT-prolonging drugs to the occurrence of beta-blocker treatment “failures”. 73
Gene symbol: KCNH2. 72
Functional characterization and molecular correction of the LQT2 KCNH2-Q376 splicing mutation. Therapeutic implications? 71
Gene symbol: KCNH2. 71
Mutation-specific risk in two genetic forms of type 3 long QT syndrome. 71
Vagal reflexes following an exercise stress test: a simple clinical tool for gene-specific risk stratification in the long QT syndrome. 71
Gene expression and arrhythmic risk. 71
The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome. 71
Symbolic analysis of heart period and QT interval variabilities in LQT1 patients 71
Time, frequency and information domain analysis of heart period and QT variability in asymptomatic long QT syndrome type 2 patients. 71
Calmodulin mutations associated with recurrent cardiac arrest in infants. 71
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes 71
Novel calmodulin mutations associated with congenital arrhythmia susceptibility. 70
Gene symbol: KCNH2 70
Congenital long QT and short QT syndromes 69
Malignant perinatal variant of long-QT syndrome caused by a profoundly dysfunctional cardiac sodium channel. 69
Ion channel diseases in children: manifestations and management. 68
Identification of Cadherin 2 (CDH2) Mutations in Arrhythmogenic Right Ventricular Cardiomyopathy. 68
Sindrome di Brugada 67
The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge. 67
Drug-induced long QT syndrome and exome sequencing: Chinese shadows link past and future. 67
Gene symbol: KCNQ1 67
Sudden cardiac death in infancy: Focus on prolonged repolarization 66
Totale 8.858
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.659
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.659
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021456 0 0 0 0 0 91 7 138 20 99 88 13
2021/2022577 13 5 33 7 13 18 7 43 34 6 90 308
2022/20232.247 232 152 27 246 194 221 2 108 907 6 124 28
2023/2024820 92 136 22 53 73 196 23 77 5 30 65 48
2024/20252.079 45 178 62 51 46 116 103 174 526 74 220 484
2025/20262.368 376 391 519 429 622 31 0 0 0 0 0 0
Totale 11.554